MLB Announces IND Approval by US FDA to Initiate Phase 1 Trial of TML-6, a New Era Multi-Target Drug for the Treatment of Alzheimer's Disease

Merry Life Biomedical Company, Ltd. Taiwan California

View original content:https://www.prnewswire.co.uk/news-releases/mlb-announces-ind-approval-by-us-fda-to-initiate-phase-1-trial-of-tml-6-a-new-era-multi-target-drug-for-the-treatment-of-alzheimers-disease-302166882.html